VANCOUVER, Jan. 21, 2020 /CNW/ – Cognetivity Neurosciences Ltd. (the “Company” or “Cognetivity”) (CSE: CGN; FWB: 1UB; OTCQB: CGNSF) today announced that…
Read More
Cognetivity Neurosciences announces regulatory approval of first CE-marked medical device Vancouver, British Columbia, January 7, 2020 – Cognetivity Neurosciences…
